U.K. contracts with Roche, Abbott for more than 10M antibody tests

By LabPulse.com staff writers

May 22, 2020 -- The U.K. government has contracted with Roche and Abbott Diagnostics to provide more than 10 million coronavirus antibody tests as part of a new screening program.

Staring next week, testing will be offered in a phased way in England, with healthcare staff getting priority but with testing also open to patients and residents, Secretary of State for Health and Social Care Matt Hancock said in a statement about the "landmark deal."

The plan is to offer "tens of thousands" of antibody tests -- which the government described as "highly accurate" -- every day.

"Knowing you have these antibodies will help us to understand in the future if you are at lower risk of catching coronavirus, dying from coronavirus and of transmitting coronavirus," Hancock said.

The government acknowledged limitations of antibody testing; for example, a positive test result doesn't guarantee a person is immune to the virus, and it's unclear whether reinfection is possible following recovery despite the presence of antibodies. The U.K. hopes to get to the bottom of these questions through an ongoing Public Health of England study, which is set to include 10,000 healthcare workers.

Meanwhile, deals with other antibody test manufacturers are in the works.

FDA pulls plug on wayward coronavirus antibody tests
The U.S. Food and Drug Administration (FDA) has published the names of 28 coronavirus antibody tests that may no longer be marketed or distributed, as...
CDC flags shortcomings of antibody tests in reopening guidelines
The U.S. Centers for Disease Control and Prevention (CDC) acknowledged high interest in antibody tests as businesses go back to work, while highlighting...
AACC provides a steer on antibody testing for novel coronavirus
The American Association for Clinical Chemistry (AACC) is advising that antibody testing for the novel coronavirus should be limited to diagnostics that...
FDA-authorized antibody tests fall short in comparative study
Commercial serology tests from PerkinElmer subsidiary Euroimmun and Abbott fell short of expectations in a comparative study of specimens, underscoring...

Copyright © 2020 LabPulse.com

Last Updated np 5/22/2020 4:01:41 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current